Introduction {#s1}
============

Cardiovascular diseases (CVDs) represent the major burden of mortality and morbidity in the developed countries ([@B9]). The most common pathogeneses of CVDs are inflammatory processes ([@B46]). Various transcription factors are related to inflammatory responses in CVDs such as T-bet ([@B18]), signal transducer and activator of transcription 3 (STAT3) ([@B27]), interferon regulatory factors (IRFs), activator protein 1 (AP-1) ([@B48]), and transcription factor Bcl11b ([@B13]). However, the key player in the regulation of inflammation is the transcription factor nuclear factor kappa B (NFκB) ([@B56]). The inhibition of NFκB pathway has been demonstrated to show beneficial effect in various CVDs including hypertension ([@B26]), myocardial infraction ([@B64]), and arteriosclerosis ([@B57]). These findings support that targeted inhibition of NFκB appears to be a promising strategy in reducing cardiovascular complications.

Flavonoids are plant polyphenolic compound derivatives from natural origin found in fruits, grains, vegetables, roots, bark, flowers, stems, tea, and wine ([@B63]). Non-plant natural products such as mushrooms and honey, plant extracts, plant juices, plant powders, and essential oils have shown to possess anti-inflammatory activities and many of these plant natural products have polyphenols as their major compound ([@B24]; [@B7]). However, the protective effects of flavonoid in CVDs *via* inhibition of NFκB are yet to be reviewed. Therefore, in this mini-review, we focused on the anti-inflammatory actions of flavonoids *via* inhibition of NFκB mechanism in CVDs.

Flavonoids and Its Subclass {#s2}
===========================

Flavonoids are categorized into six subclasses depending on its chemical structures: flavones, flavonols, flavanones, isoflavones, flavan-3-ols, and anthocyanidins ([@B40]).

Flavones are found abundant in flowers, fruits, and leaves such as red peppers, celery, parsley, chamomile, mint, and ginkgo biloba ([@B34]). The most studied flavones are luteolin, apigenin, and tangeritin ([@B34]).

Flavonols such as kaempferol, myricetin, quercetin, rutin, fisetin, silymarin, and isorhamnetin are ubiquitous in foods such as saffron, onions, kale, lettuce, tomatoes, apples, grapes, berries, red wine, and tea ([@B42]).

Flavanones widely present in all citrus fruits, which gives the bitter taste of the juice and its peel. Oranges, lemons, and grapes are rich sources of flavanones and major compounds are hesperitin, naringenin, and eriodictyol ([@B8]).

Isoflavones are unique in that they resemble estrogen in structure and, therefore, are classified as phytoestrogens. There are found abundantly in soy products such as tofu, roasted soy nuts, and miso ([@B36]).

Flavan-3-ols, also called as dihydroflavonols, include catechin, epicatechin, gallocatechin, epigallocatechin, epicatechingallate, epigallocatechingallate, and procyanidin ([@B2]). The most commonly associated food with the flavan-3-ol compounds is black and green tea and fruits such as bananas, apples, blueberries, peaches, and pears ([@B37]).

Anthocyanins are rich in outer cell layers of fruits such as merlot grapes, raspberries, cranberries, red grapes, strawberries, blueberries, bilberries, and blackberries. The most commonly studied anthocyanins are cyanidin, delphinidin, malvidin, pelargonidin, and peonidin ([@B25]).

Nfκb Induced Inflammation and CVDs {#s3}
==================================

There are a few cellular redox pathways involved in the development of the chronic inflammatory CVD, which includes NFκB. NFκB is a transcription factor that activates inhibitor of kappa B (IκB) kinase in the cytosol upon being stimulated by inflammatory stimuli ([@B10]). Subsequent signaling pathways *via* canonical or non-canonical lead to migration of NFκB toward the nucleus and hence initiates the targeting gene such as pro-inflammatory cells, monocytes, macrophages, and T and B cells ([**Figure 1**](#f1){ref-type="fig"}).

![Mechanism of NFκB action. In inactivated state, NF-κβ, which consists of Rel and p50 proteins, is located in the cytosol complexed with the inhibitory protein Iκβα. IκB kinase (IKK) is activated by extracellular signals *via* membrane receptors. Subsequently, IKK phosphorylates the Iκβα protein resulting in ubiquitination of Iκβα and eventually by the proteasome for Iκβα degradation (canonical pathway). In non-canonical pathway, RelB favors the activation of NF-κβ *via* RelB. Activated NF-κβ is further translocated into the nucleus for DNA bindings, called response elements (RE). The DNA/NF-κβ complex attracts coactivators and RNA polymerase, which transcribe the DNA into mRNA resulting in a cell transformation.](fphar-10-01295-g001){#f1}

The canonical NFκB pathway responds rapidly to stimuli and activates NFκB, which increases pro-inflammatory cytokines such as interleukin (IL)-1β, IL-6, and tumor necrosis factor alpha (TNF-α), which results in cell apoptosis. TNF-α receptor signaling plays an important role in the canonical pathway of NFκB in cell death *via* Jun N-terminal kinases (JNK), p38, and caspase 8 cascades ([@B16]). Furthermore, NFκB also activates angiotensin II, endothelin-1, and phenylephrine as hypertrophic agonist *via* IκB degradation and p65 nuclear translocation.

A central signaling component of the non-canonical NFκB pathway is NFκB-inducing kinase, which induces p100 phosphorylation through kinase IKKα in a slow manner ([@B52]). Ligands of a subset of tumor necrosis factor receptor (TNFR) superfamily members are typical inducers of the non-canonical NFκB pathway ([@B47]).

Anti-Inflammatory Effects of Flavonoids in CVDs *via* Modulation of NFκB Signaling {#s4}
==================================================================================

Quercetin {#s4_1}
---------

Quercetin or 3, 3′, 4′, 5, 7-pentahydroxyflvanone that falls into the category of flavonol is widely found in plants such as Ginkgo biloba, *Hypericum perforatum*, and *Sambucus canadensis* as well as vegetables such as apples, berries, grapes, onions, shallots, and tomatoes ([@B31]).

In a clinical study involving patients with chronic systemic inflammation (CSI) in stable coronary artery disease (CAD), quercetin showed anti-inflammatory effects with reduction in indicators of CSI ([@B11]). Quercetin decreased IL-1β and TNF-α levels in blood serum, in addition to decreasing the transcriptional activity of NFкB in blood mononuclear cells ([@B11]). In leptin-induced inflammation model using human umbilical vein endothelial cells (HUVECs), quercetin significantly suppressed the upregulation of Ob-Ra (leptin receptor) expression, ERK1/2 phosphorylation, NFкB, and TNF-α ([@B22]). Furthermore, in a neonatal rat cardiac fibroblast, quercetin inhibited TNF-α, IL-1β, and IL-6 secretion by inhibiting the activation of NFкB and Akt induced by lipopolysaccharide (LPS) ([@B54]).

Luteolin {#s4_2}
--------

Luteolin or 3', 4', 5, 7-tetrahydroxyflavone is one of the most prevalent flavones widely found in fruits and vegetables such as carrots, cabbages, parsley, broccoli, celery, and apple skins ([@B58]).

In an *in-vivo* sodium fluoride-induced hypertensive model, administration of luteolin increased nitric oxide (NO) bioavailability, reversed prolongation of QT and QTc intervals, and reduced the expressions of kidney injury marker 1 (Kim-1), NFκB, and cardiac troponin I (CTnI), which eventually normalized the blood pressure ([@B38]). Previous study in neonatal rat cardiac myocytes exposed to LPS showed luteolin reduced the TNF-α levels in the medium, downregulated the TNF-α mRNA in myocytes, inhibited degradation of IκB-β and nuclear translocation of NFκB, as well as reduced NFκB DNA binding, proposing the therapeutic potential of luteolin the management of inflammation-related myocardial diseases ([@B33]).

Fisetin {#s4_3}
-------

Fisetin or 3, 3c,4c,7-tetrahydroxyflavone is a bioactive molecule found in fruits such as strawberry, apple, persimmon, and grape and vegetables such as onion and cucumber ([@B4]).

[@B15] reported the protective effect of fisetin against isoproterol-induced myocardial injury by suppressing myocardial injury markers, creatine kinase-muscle/brain (CK-MB), lactate dehydrogenase (LDH), and inflammatory markers (TNF-α and IL-6) in the blood serum as well as normalization of histological and ultrastructure of the heart. In addition, fisetin regulated the balance between pro- or anti-oxidants and pro- or anti-apoptotics proteins in the myocardial tissue ([@B15]). These protective effects of fisetin are attributed to the downregulation of receptor for advanced glycation end products (RAGE) and NFκB ([@B15]).

Fisetin attenuated the development of diabetic cardiomyopathy by attenuating the expression of myocardial NFκB and the pro-inflammatory cytokines IL-1β, IL-6, and TNF-α in the heart of diabetic rats. These result in reduction of cardiac function markers such as CK-MB, LDH, and cTn as well as normalization heart morphology ([@B3]).

Apigenin {#s4_4}
--------

Apigenin, a flavone, is found widely available in fruits and vegetables, such as grapefruits, oranges, celeries, and onions ([@B45]).

In LPS-treated macrophages, apigenin has been shown to reduce toll-like receptor 4 (TLR-4), MyD88, and p-IκB-α expression levels *via* nuclear NFκB p65 signaling pathway ([@B45]). Similarly, in LPS-challenged apoE-/- mice, treatment with apigenin increased expression of ATP binding cassette A1 (ABCA1), which alleviated extra lipid accumulation, reduced miR-33, TLR-4, and NFκB p65 levels, lessened the macrophages and smooth muscle cell contents in the atherosclerotic region, and improved plasma lipid profile ([@B45]). These results suggested that apigenin attenuates atherogenesis by inhibition of nuclear NFκB p65 that up-regulates ABCA1-mediated cholesterol efflux ([@B45]).

Apigenin was also shown to improve cardiac dysfunction and fibrosis in diabetic cardiomyopathy. Apigenin blunted the activity of NFκB and downregulated the activity of caspase3 accompanying with decreasing oxidative stress marker, glutathione peroxidase (GSH-Px), malondialdehyde (MAD), and superoxide dismutase (SOD) ([@B20]).

Isoliquiritigenin {#s4_5}
-----------------

Isoliquiritigenin is extracted from root of licorice and has been used traditionally for the treatment of inflammatory or pulmonary diseases ([@B41]). In HUVECS exposed to TNF-α, isoliquiritigenin blocked the involvement of NFкB at the transcriptional levels, and thus attenuated the downstream expression of VCAM-1, E-selectin, THP-1 monocyte adhesion, IкB-α, and PECAM-1, suggesting the protective effects of isoliquiritigenin through NFкB-dependent mechanisms ([@B28]). In angiotensin II induced hypertension model, isoliquiritigenin attenuated inflammation cytokines including IL-1β and TNF-α, excessive deposition of extracellular matrix, and oxidative stress-induced apoptosis *via* nuclear factor E2-related factor 2 (Nrf2) and NFκB pathways ([@B59]).

Rutin {#s4_6}
-----

Rutin is a flavonol that presents in buckwheat and citrus fruits. In a sodium fluoride-induced hypertensive rats, administration of rutin reduced blood pressure elevation by enhancing NO bioavailability *via* down-regulation of NFκB expression and up-regulation of Nrf2 ([@B39]).

In carfilzomib-induced cardiotoxicity in rat, rutin protected against myocardial hypertrophy by upregulating IκB-α and downregulating NFκB expression, resulting in attenuation of β-myosin heavy chain, reduction in B-type natriuretic peptide mRNA expressions, and normalization of cardiac muscle ﬁber morphology ([@B21]).

In addition, rutin increased activities of Nrf, decreased activation of NFκB in human embryonic kidney reporter cell line, and preserved relaxation of fetal placental arteries derived from human chorionic plate ([@B49]).

In high mobility group box 1 (HMGBI)-induced inflammatory response in HUVECs, rutin attenuated NFκB and ERK1/2, which, in turn, reduced IL-6 and TNF-α levels ([@B62]). Up-regulation of VCAM-1, intercellular adhesion molecule-1 (ICAM-1), and E-selectin induced by HMGB1 were similarly inhibited by rutin, suggesting that the protective effect of rutin on vascular inflammation is by inhibiting the HMGB1 and NFκB pathways.

In LPS-induced inﬂammation in HUVECs, rutin reversed barrier disruption, expression of cell adhesion molecules, and adhesion and migration of monocytes in endothelial cells. The barrier protective effects of rutin were linked to a down-regulation of TNF-α, deactivation of NFκB, and reduced phosphorylation of IκB-α ([@B29]).

Chrysin {#s4_7}
-------

Chrysin (5,7-dihydroxyﬂavone) is a flavone, which is found in the blue passion ﬂower, honey, and propolis ([@B35]). Chrysin prevented doxorubicin (DOX)-induced cardiomyopathy including disturbance of cardiac conduction, increased serum cardiac markers and histopathological alteration in heart of rat *via* downregulation of NFκB, mitogen-activated protein kinase (MAPK), suppression of AKT pathway and its upstream activator, vascular endothelial growth factor (VEGF) ([@B35]).

In a rat model of monocrotaline-induced pulmonary arterial hypertension (PAH), chrysin reduced right ventricular systolic pressure and mean pulmonary artery pressure. In addition to suppression of right ventricular remodeling, chrysin abolished increased expression of collagen I, collagen III, and NFκB ([@B30]).

In isoprenaline-induced myocardial injury in rats, chrysin relieved hemodynamic and ventricular dysfunction as well as reduced ultrastructural myocardial damage *via* inhibition of NFκB, IκKβ expression, and TNF-α level as well as increased peroxisome proliferator-activated receptor-gamma (PPAR-γ) expression ([@B44]).

In a rat model of myocardial infarction, fibrosis in the interstitial and perivascular regions and expression of collagen was reduced following chrysin treatment ([@B61]). This effect is associated with increased PPAR-γ expression and decreased NFκB expression *via* inhibition of IκKβ phosphorylation, leading to reduction of matrix metalloproteinase-2 (MMP-2), MMP-9 levels, and suppression of activator protein 1 (AP-1) level.

Genistein {#s4_8}
---------

Genistein under the subgroup of an isoflavone \[4′,5,7-trihydroxyisoflavone,5,7-dihydroxy-3-(4-hydroxyphenyl)-4-H-1-benzopyran-4-one\] is primarily found in soy-based foods, legumes, and red clover. In homocysteine-induced endothelial cell inﬂammatory injury, genistein prevented endothelial damage *via* blockade of activation of NFκB, expression of inflammatory cytokine and adhesion molecule, IL-6, and ICAM-1 ([@B17]).

[@B60] explored the effect of genistein on angiotensin II-induced vascular smooth muscle cell inflammation. Angiotensin II-induced expression of NFκB, C-reactive protein (CRP), MMP-9, phosphorylation of ERK1/2 and p-38, which lead to atherosclerotic inflammatory damage, were reversed following genistein treatment. Furthermore, genistein enhanced expression of PPAR-γ, suggesting cardiovascular protective effect by the isoflavone is through regulation of p38/ERK1/2-PPARγ-NFκB signaling pathway ([@B60]).

Silymarin {#s4_9}
---------

Silymarin is a flavonolignan extracted from the milk thistle. Silymarin augmented relaxation of pulmonary arteries isolated from a lung ischemia-reperfusion (I/R) injury model ([@B23]). Vascular protective effect of silymarin is due to inhibition of NFκB, thus suppressing the serum concentration of inflammatory cytokines and reducing protein expression of hypoxia inducible factor-1α (HIF-1α) and iNOS.

Silibinin, a major active constituent of silymarin, was able to reduce the abnormal size of cardiac myocytes and prevent hypertrophy by alleviating the production of epidermal growth factor receptor (EGFR) ([@B1]). Silibilin exerted its anti-inflammatory effect by suppressing the activation of NFκB stimulated by angiotensin II in cardiac myocytes or in the aortic banding male mice. Furthermore, silibilin interfered with the phosphorylation and degradation of IκB-α and activation of IκKβ *in vivo*.

Kaempferol {#s4_10}
----------

Kaempferol (3,4′,5,7-tetrahydroxyflavone) is a flavonol that is present widely in fruits, vegetables, and herbs, including grapes, tomatoes, and tea. In cardiac fibroblasts stimulated with LPS, kaempferol decreased release of pro-inflammatory cytokines by inhibiting AKT phosphorylation and NFκB activation ([@B53]). In isoprenaline-induced cardiac damage, kaempferol improved the hemodynamic and left ventricular functions in male rats, which abated the increased serum concentration of CK-MB and LDH, preserved the morphology of myocardium, and reduced the levels of pro-inflammatory cytokines ([@B50]). Similarly, kaempferol prevented cardiac damage by inhibiting the protein expression of NFκB, p38, and JNK ([@B51]) suggesting that cardioprotective and anti-inflammatory action of kaempferol was associated with NFκB signaling pathway.

[**Table 1**](#T1){ref-type="table"} summarizes the effects and mechanisms of action of flavonoids in CVD.

###### 

Effect of flavonoids in CVDs.

  No   Flavonoids           Models                                                                          Mechanisms                                                            Reference
  ---- -------------------- ------------------------------------------------------------------------------- --------------------------------------------------------------------- ------------------
  1    Quercetin            Clinical study: CAD patients                                                    ↓ NFкB, IL-1β, TNF-α, IkBα                                            ([@B11])
                            *In vitro*: leptin-induced inflammation and endothelial dysfunction in HUVECs   ↓ ERK1/2 phosphorylation, NFкB, TNF-α                                 ([@B22])
                            *In vitro*: neonatal rat cardiac fibroblast inflammatory                        ↓ NFкB, TNF-α, IL-1β, IL-6, AKT                                       ([@B54])
  2    Luteolin             *In vivo*: NaF-induced hypertension                                             ↑NO ↓ Nrf2, Kim-1, NFκB, CTnI                                         ([@B38])
                            *In vitro*: Neonatal rat cardiac myocytes inflammatory                          ↓ NFκB, TNF-α, ↑ IκB-β                                                ([@B33])
  3    Fisetin              *In vivo*: Isoprenaline-induced cardiac ischemic injury                         ↓NFκB, RAGE, TNF-α, IL-6, CK-MB, LDH                                  ([@B15])
                            *In vivo*: Hyperglycemia-induced cardiac injury                                 ↓NFκB, IL-1β, IL-6, TNF-α                                             ([@B3])
  4    Apigenin             *In vitro*: LPS-treated macrophages *In vivo*: LPS-challenged apoE-/- mice      ↓ NFκB p65, TLR-4, MyD88, p-IκB-α ↑ ABCA1                             ([@B45])
                            *In vivo*: diabetic cardiomyopathy                                              ↓ NFκB, caspase3, GSH-Px, MDA, SOD                                    ([@B20])
  5    Isoliquiriti-genin   *In vitro*: TNF-α induced inflammation in HUVECs                                ↓ NFкB, VCAM-1, E-selectin, THP-1 monocyte adhesion, IкB-α, PECAM-1   ([@B28])
                            *In vivo*: Angiotensin II-induced hypertension                                  ↓ NFкB, IL-1β and TNF-α Nrf2,                                         ([@B59])
  6    Rutin                *In vivo:* Sodium fluoride induced hypertension in rat                          ↓ NFκB ↑ Nrf2                                                         ([@B39])
                            *In vivo:* carfilzomib-induced cardiotoxicity in rat                            ↓ NFκB ↑ IκB-α                                                        ([@B21])
                            *In vitro*: hydrogen peroxide induced oxidative stress in HUVECS                ↓ NFκB ↑ Nrf2                                                         ([@B49])
                            *In vitro*: HMGBI-induced inflammatory in HUVECS                                ↓ NFκB, ERK1/2, TNFα, IL-6, ICAM-1, VCAM-1, E-selectin                ([@B62])
                            *In vitro*: LPS induced inflammation in HUVECS                                  ↓ NFκB, IκB-α, TNF-α, ICAM-1, VCAM-1, E-selectin                      ([@B29])
  7    Chrysin              *In vivo:* DOX-induced cardiotoxicity in rat                                    ↓ p38, JNK, NFκB ↑ VEGF, AKT                                          ([@B35])
                            *In vivo:* monocrotaline-induced pulmonary arterial hypertension in rat         ↓ NFκB                                                                ([@B30])
                            *In vivo:* ISO-induced myocardial injury in rat                                 ↑ PPAR-γ ↓ NFκBp65, IκK-β, TNF-α                                      ([@B44])
                            *In vivo*: MI in rat                                                            ↑ PPAR-γ ↓ NFκB, IκK-β, MMP-2, MMP-9, AP-1                            ([@B61])
  8    Genistein            *In vitro*: Homocysteine-induced endothelial cell inﬂammation in HUVECS         ↓ NFκBp65, IL-6, ICAM-1                                               ([@B17])
                            *In vitro*: angiotensin II-induced VSMCs inflammation                           ↑ PPAR-γ ↓ ERK1/2, p38, NFκB, CRP, MMP-9                              ([@B60])
  9    Silymarin            *In vivo:* I/R injury in rat                                                    ↓ NFκB, HIF-1α, iNOS, TNFα, IL-1β, IL-6                               ([@B23])
                            *In vivo:* Cardiac hypertrophy model in mouse                                   ↓ NFκB, EGFR, IκB-α, IκKβ                                             ([@B1])
  10   Kaempferol           *In vitro*: LPS+ATP stimulated cardiac fibroblasts inflammation                 ↓ AKT, NFκBp65, TNF-α, IL-1β, IL-6, IL-18                             ([@B53])
                            *In vivo*: I/R cardiac injury in rat                                            ↓ p38, JNK, NFκBp65, TNF-α, IL-6                                      ([@B50]; [@B51])

Conclusion {#s5}
==========

The actions of flavonoids in mitigating inflammation by modulation of NFкB offer potential agents for the treatment of CVDs. However, several of these actions reported *in vitro* may yet to be fully recognized due to their low bioavailabilities following oral administration ([@B19]; [@B55]). Flavonoids have shown promising results in reducing atherosclerosis in several animal experimental models; however, conflicting results were reported in human clinical trials ([@B6]; [@B65]). The low bioavailability and clinical efficacy of flavonoids are attributed to their poor absorption, metabolism by the metabolizing enzymes in the intestine and liver, and structural modifications by the colonic bacteria remain as the major problems. Continuous investigation is required to enhance the bioavailability and efficacy of the flavonoids to tap the full potential of these natural agents.
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